Doctor Miroslav Mihajlovic

Back

Doctor Miroslav Mihajlovic

University Clinical Center of Serbia, Belgrade (Serbia)

Member of:

Presentations Articles

Cluster-specific predictors of early rhythm control in contemporary European cohort of patients with atrial fibrillation: The EHRA-PATHS Project

Event: ESC Congress 2024

Topic: Treatment

Session: Rhythm control in atrial fibrillation: prognostic and therapeutic implications

Access

Cluster-specific risk factors for suboptimal thromboprophylaxis in contemporary European cohort of patients with atrial fibrillation: the EHRA-PATHS Project

Event: ESC Congress 2024

Topic: Treatment

Session: Stroke risk management in atrial fibrillation registries: key take-home messages for clinicians

Access

Patient-reported treatment burden: comparison between vitamin-K antagonist and non-vitamin K antagonist oral anticoagulants

Event: EHRA 2024

Topic: Oral Anticoagulation

Session: Poster session on devices, others

Access

Sex-related differences in self-reported treatment burden in patients with atrial fibrillation

Event: EHRA 2021

Topic: Treatment

Session: ePoster session

Access

Main determinants of physician-driven amiodarone discontinuation in clinical practice

Event: EHRA 2021

Topic: Antiarrhythmic Drug Treatment

Session: New approaches for ablation

Access

Amiodarone in contemporary clinical practice: the rates of and reasons for permanent drug discontinuation

Event: ESC Congress 2019

Topic: Antiarrhythmic Pharmacotherapy

Session: Anti-arrhythmic drug therapy: new concepts on old drugs

Access

Amiodarone treatment duration and reasons for permanent drug discontinuation in patients with atrial fibrillation

Event: ESC Congress 2019

Topic: Rhythm Control, Antiarrhythmic Drugs

Session: Drug treatment for atrial fibrillation

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Miroslav Mihajlovic Follow

Contributor content

Cluster-specific predictors of early rhythm control in contemporary European cohort of patients with atrial fibrillation: The EHRA-PATHS Project

Cluster-specific risk factors for suboptimal thromboprophylaxis in contemporary European cohort of patients with atrial fibrillation: the EHRA-PATHS Project

Patient-reported treatment burden: comparison between vitamin-K antagonist and non-vitamin K antagonist oral anticoagulants

Sex-related differences in self-reported treatment burden in patients with atrial fibrillation

Main determinants of physician-driven amiodarone discontinuation in clinical practice

Amiodarone in contemporary clinical practice: the rates of and reasons for permanent drug discontinuation

Amiodarone treatment duration and reasons for permanent drug discontinuation in patients with atrial fibrillation

ESC 365 is supported by

Doctor Miroslav Mihajlovic